Bland Altman plot comparing S_cvO₂_CeVOX_fem to S_cvO₂_BGA derived from measurements with <i>femoral</i> CVC.

<p>S_cvO₂_CeVOX_fem: Central venous oxygen saturation derived from the CeVOX-device. S_cvO₂_BGA: Central venous oxygen saturation derived from blood gas analysis. CVC: Central venous catheter.</p

Univariate association of different variables to S_cvO₂_CeVOX–S_cvO₂ and the amount |S_cvO₂_CeVOX–S_cvO₂|.

<p>Univariate association of different variables to S_cvO₂_CeVOX–S_cvO₂ and the amount |S_cvO₂_CeVOX–S_cvO₂|.</p

Experimental and clinical studies on the use of CeVOX.

<p>Experimental and clinical studies on the use of CeVOX.</p

Correlation of the amount of the bias |S_cvO₂_CeVOX–ScvO2_BGA| with a prediction formula derived from the total datset (n = 120).

<p>S_cvO₂_CeVOX: Central venous oxygen saturation derived from the CeVOX-device. S_cvO₂_BGA: Central venous oxygen saturation derived from blood gas analysis.</p

Bland Altman plot comparing S_cvO₂_CeVOX_jug to S_cvO₂_BGA derived from measurements with <i>jugular</i> CVC.

<p>S_cvO₂_CeVOX_jug: Central venous oxygen saturation derived from the CeVOX-device. S_cvO₂_BGA: Central venous oxygen saturation derived from blood gas analysis. CVC: Central venous catheter.</p

Bland Altman plot comparing S_cvO₂_CeVOX to S_cvO₂_BGA derived from all measurements (jugular or femoral CVC).

<p>S_cvO₂_CeVOX: Central venous oxygen saturation derived from the CeVOX-device. S_cvO₂_BGA: Central venous oxygen saturation derived from blood gas analysis. CVC: Central venous catheter.</p

ROC curve comparing different predictors of |S_cvO₂_CeVOX–S_cvO₂_BGA| ≥5% in the independent <i>validation</i> group (n = 40).

<p>Prediction of |bias|: model predicting |S_cvO₂_CeVOX–S_cvO₂_BGA| which was derived from multiple regression analysis within the <i>evaluation</i> group. ROC: receiver operating characteristic. AUC: area under the curve. S_cvO₂_CeVOX: Central venous oxygen saturation derived from the CeVOX-device. S_cvO₂_BGA: Central venous oxygen saturation derived from blood gas analysis.</p

Patients characteristics.

<p>Patients characteristics.</p

ROC curve comparing different predictors of |S_cvO₂_CeVOX–S_cvO₂_BGA| ≥5% in the <i>evaluation</i> group (n = 80).

<p>“Prediction of |bias|”: model predicting |S_cvO₂_CeVOX–S_cvO₂_BGA| which was derived from multiple regression analysis within the evaluation group. ROC: receiver operating characteristic. AUC: area under the curve. S_cvO₂_CeVOX: Central venous oxygen saturation derived from the CeVOX-device. S_cvO₂_BGA: Central venous oxygen saturation derived from blood gas analysis.</p

Comparison of pulmonary vascular permeability index PVPI and global ejection fraction GEF derived from jugular and femoral indicator injection using the PiCCO-2 device: A prospective observational study - Fig 1

<p><b>1A-1F:</b> Bland Altman plots comparing (1A) pulmonary vascular permeability index PVPI_fem_uncor derived from femoral injection without activating of a potential correction by the device to the gold standard measurement PVPI_jug using a jugular CVC for indicator injection, <b>(1B)</b> pulmonary vascular permeability index PVPI_fem_cor derived from femoral injection after activiation of a potential correction by the device to the gold standard measurement PVPI_jug using a jugular CVC for indicator injection, <b>(1C)</b> pulmonary vascular permeability index PVPI derived from femoral indicator injection with (PVPI_fem_cor) and without (PVPI_fem_uncor) activation of a potential correction by the device, <b>(1D)</b> pulmonary vascular permeability index PVPI derived jugular indicator injection PVPI_jug to PVPI-fem_uncor_form which was derived from femoral indicator injection without activation of a potential correction by the device, but correction based on the formula suggested for correction of femoral indicator injection derived GEDVI: GEDVI_corrected [mL / m²] = 0.539 * GEDVI_uncorrected—15.17 + 24.49 * CI_uncorrected 2.311* BW_ideal. PVPI_fem_uncor_form was calculated by multiplying PVPI_fem_uncor with the ratio 0.25*GEDV_uncorrected/0.25*GEDV_corrected, <b>(1E)</b> global ejection fraction GEF_fem_uncor derived from femoral injection without activating of a potential correction by the device to the gold standard measurement GEF_jug using a jugular CVC for indicator injection, <b>(1F)</b> global ejection fraction GEF_fem_cor derived from femoral injection after activiation of a potential correction by the device to the gold standard measurement GEF_jug using a jugular CVC for indicator injection, <b>(1G)</b> global ejection fraction GEF derived from femoral indicator injection with (GEF_fem_cor) and without (GEF_fem_uncor) activation of a potential correction by the device.</p